The sixth annual National Policy & Advocacy Summit on Biologics brought together health
care providers, policy experts, patient advocates and other stakeholders. The event explored
how sound public policies can facilitate the expanded use of biologics in patient-centered
care. This year’s event, held virtually, examined issues such as:
- Innovation and rare disease
- Current federal and state policy considerations
- The role of biosimilars in expanding treatment options
- Insulin affordability and interchangeable biosimilars
Click below to read the report.
